Käyttäjä33343
Seuratut keskustelut
Kommentit
https://www.thisislocallondon.co.uk/news/national/19020838.lateral-flow…
Lupaava testi oireettomien nopeaan testaukseen. Mullistaa testauksen koko Britanniassa.
More than 37,000 people with a symptomless Covid-19 infection have been detected through rapid lateral flow testing, the chief medical adviser for NHS Test and Trace has said.
Dr Susan Hopkins said the devices, which can give results in less than 30 minutes, were being rolled out across the country to enable those with no coronavirus symptoms to be tested.
Lateral flow tests are regularly used by NHS staff.
Käyttäjä33343 kirjoitti:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)3262…
Oxford–AstraZeneca COVID-19 vaccine efficacy.
The observed differences in efficacy by dose were not consistent with results from previous immunogenicity trials of this vaccine, which were similar for participants receiving two low doses and two standard doses; no immunogenicity data exist for the mixed-dose regimen.6 If immunogenicity is also similar for this regimen, this would be an unusual finding that requires further exploration, including whether this pertains only to milder disease (as there were too few cases to assess efficacy against severe COVID-19). Disparity between immunogenicity and efficacy findings could imply that clear-cut immunological correlates of clinical protection might not exist for COVID-19 vaccines,
Elikkäs tuo Rämetinkin ehdottama
puolittaminen on ollut näissä esillä
mutta vaatii lisätutkimuksia.Rohkea hyppy olisi, jos täällä mentäisiin puolittelemaan tuosta vain ja katsotaan miten meni. Perästäpäin.
THL:n ylilääkäri ehdotuksesta puolittaa koronarokotteen tehosteannos: ”Fiksu ajatus, ja sitä voidaan harkita”
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)3262…
Oxford–AstraZeneca COVID-19 vaccine efficacy.
The observed differences in efficacy by dose were not consistent with results from previous immunogenicity trials of this vaccine, which were similar for participants receiving two low doses and two standard doses; no immunogenicity data exist for the mixed-dose regimen.6 If immunogenicity is also similar for this regimen, this would be an unusual finding that requires further exploration, including whether this pertains only to milder disease (as there were too few cases to assess efficacy against severe COVID-19). Disparity between immunogenicity and efficacy findings could imply that clear-cut immunological correlates of clinical protection might not exist for COVID-19 vaccines,
Elikkäs tuo Rämetinkin ehdottama
puolittaminen on ollut näissä esillä
mutta vaatii lisätutkimuksia.
Rohkea hyppy olisi, jos täällä mentäisiin puolittelemaan tuosta vain ja katsotaan miten meni. Perästäpäin.
Outoa lensua kun alentaa usan elämänpituutta, odotettua 1.1 v.
The average US life expectancy will likely drop 1.1 year due to covid-19, and more for Black and Latino populations
https://pnas.org/content/1
Uskomaton farssi taas käsissä.
Sanotaan, että kolmannes rokotteista olisi jo kadonnut.